Nevertheless, the recent opportunity of measuring NfL in the plasma through the Simoa assay, in even smaller quantities than before, has made NfL a valuable peripheral biomarker to assess cognitive decline and to identify individuals at risk of neurodegeneration and brain atrophy [58,59]. Here, NEFL is linked to Brain atrophy.